Hwa-Kyung Park

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Patient Reported Outcomes

Cross Sectional

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)
Cheol-Kyu Park, Nakyung Jeon, Hwa-Kyung Park, Hyung-Joo Oh, Young-Chul Kim, Ha Lim Jeon, Yong-Hyub Kim, Sung-Ja Ahn, In Jae Oh
A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers 15 (5) (2023)